Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Jul 12, 2022 10:08am
166 Views
Post# 34817728

RE:RE:RE:RE:RE:RE:A must watch PMX presentation by Dr. Kellum

RE:RE:RE:RE:RE:RE:A must watch PMX presentation by Dr. KellumI suspect that of the tiny fraction of people that know about  Spectral, most of them think that the EAA is only to be used in conjunction with PMX as a companion diagnostic.

What they don't appreciate is that (IMO) the EAA should be used in ICU's world-wide as a triage tool to look for elevated levels of endotoxins when a patient presents with a multiple of symptoms.  It could be flu, Covid, low BP, dizziness, fever, etc.  And the Doc's at the Conference are now on to the idea that a patients can be endotoxemic, yet culture NO bacteria !  (as was partially proven under Euphrates - and where there was a significant mortality benefit albeit in a small subset)    Does this mean some people are in danger of being sent home from ICUs with no antibiotics?  All while endoxins leach into their blood stream from their guts?   Only to become severely septic - when every hour in teh treatment of Sepsis counts?

It seems to me that the EAA should be used WAY more widely than just in conjunction with PMX treatments. But I'm no doctor.  If I was, I think that I would be pounding the table about this.

And millions more EAA's would be sold, worldwide.

 6 million Jewish heritage people were killed in WWII over 5 years.  6 million people have died from Covid over 2-3 years.  Did those events get any media attention? Pre-Covid, worldwide, >10 million peeps died each and every year from Sepsis.  Post Covid - that figure may be up.

MM 
<< Previous
Bullboard Posts
Next >>